Inhibikase Therapeutics shares owned by Blackstone Group
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Blackstone Group
from 13F filings
Historical chart of Blackstone Group investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Blackstone Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.3M | 2.6M | 1.62 |
| 2025-06-30 | $5.1M | 2.6M | 1.95 |
| 2025-03-31 | $4.5M | 2.1M | 2.19 |
| 2024-12-31 | $6.7M | 2.1M | 3.25 |